Sfe Investment Counsel Becton Dickinson & CO Transaction History

Sfe Investment Counsel

$462 Million
Q3 2024

A detailed history of Sfe Investment Counsel transactions in Becton Dickinson & CO stock. As of the latest transaction made, Sfe Investment Counsel holds 22,222 shares of BDX stock, worth $5.08 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares

22,222

Previous 21,230 4.67%

Holding current value

$5.08 Million

Previous $4.96 Million 7.98%

% of portfolio

1.16%

Previous 1.13%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$221.47 - $242.41 $219,698 - $240,470	992 Added 4.67%	22,222 $5.36 Million
Q2 2024 Aug 05, 2024	SELL	$225.07 - $246.17 $66,620 - $72,866	-296 Reduced 1.38%	21,230 $4.96 Million
Q1 2024 May 03, 2024	SELL	$233.45 - $247.73 $1.13 Million - $1.2 Million	-4,859 Reduced 18.42%	21,526 $5.33 Million
Q4 2023 Jan 31, 2024	SELL	$232.24 - $267.23 $167,909 - $193,207	-723 Reduced 2.67%	26,385 $6.43 Million
Q3 2023 Oct 24, 2023	SELL	$254.9 - $283.59 $116,234 - $129,317	-456 Reduced 1.65%	27,108 $7.01 Million
Q2 2023 Jul 24, 2023	SELL	$238.39 - $265.32 $31,705 - $35,287	-133 Reduced 0.48%	27,564 $7.28 Million
Q1 2023 May 08, 2023	SELL	$229.71 - $259.35 $186,983 - $211,110	-814 Reduced 2.86%	27,697 $6.86 Million
Q4 2022 Feb 09, 2023	SELL	$218.29 - $256.91 $25,539 - $30,058	-117 Reduced 0.41%	28,511 $7.25 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $6,225 - $32,236	122 Added 0.43%	28,628 $6.38 Million
Q2 2022 Aug 10, 2022	SELL	$234.74 - $275.42 $33,567 - $39,385	-143 Reduced 0.5%	28,506 $7.03 Million
Q1 2022 May 06, 2022	SELL	$243.64 - $270.48 $245,832 - $272,914	-1,009 Reduced 3.4%	28,649 $7.62 Million
Q4 2021 Feb 07, 2022	BUY	$230.08 - $250.94 $312,448 - $340,776	1,358 Added 4.8%	29,658 $7.46 Million
Q3 2021 Nov 12, 2021	SELL	$232.72 - $256.47 $17,686 - $19,491	-76 Reduced 0.27%	28,300 $6.96 Million
Q2 2021 Aug 10, 2021	BUY	$232.65 - $254.58 $210,548 - $230,394	905 Added 3.29%	28,376 $6.9 Million
Q1 2021 Apr 30, 2021	BUY	$232.09 - $256.88 $655,422 - $725,429	2,824 Added 11.46%	27,471 $6.68 Million
Q4 2020 Feb 04, 2021	BUY	$221.92 - $245.94 $614,052 - $680,515	2,767 Added 12.65%	24,647 $6.17 Million
Q3 2020 Nov 09, 2020	SELL	$215.77 - $276.76 $83,071 - $106,552	-385 Reduced 1.73%	21,880 $5.09 Million
Q2 2020 Aug 05, 2020	BUY	$219.9 - $263.41 $28,587 - $34,243	130 Added 0.59%	22,265 $5.33 Million
Q1 2020 May 04, 2020	SELL	$195.69 - $279.01 $233,849 - $333,416	-1,195 Reduced 5.12%	22,135 $5.09 Million
Q4 2019 Jan 17, 2020	SELL	$236.45 - $266.82 $21,044 - $23,746	-89 Reduced 0.38%	23,330 $6.35 Million
Q3 2019 Oct 31, 2019	SELL	$230.58 - $256.08 $61,103 - $67,861	-265 Reduced 1.12%	23,419 $5.92 Million
Q2 2019 Jul 26, 2019	BUY	$217.4 - $246.08 $348,492 - $394,466	1,603 Added 7.26%	23,684 $5.97 Million
Q1 2019 May 08, 2019	SELL	$206.05 - $248.17 $96,225 - $115,895	-467 Reduced 2.07%	22,081 $5.51 Million
Q4 2018 Feb 07, 2019	SELL	$204.73 - $257.93 $229,911 - $289,655	-1,123 Reduced 4.74%	22,548 $5.08 Million
Q3 2018 Oct 31, 2018	SELL	$233.07 - $256.0 $219,785 - $241,408	-943 Reduced 3.83%	23,671 $6.18 Million
Q2 2018 Jul 30, 2018	BUY	$208.1 - $233.85 $4,162 - $4,677	20 Added 0.08%	24,614 $5.9 Million
Q1 2018 May 01, 2018	SELL	$205.46 - $240.27 $424,069 - $495,917	-2,064 Reduced 7.74%	24,594 $5.33 Million
Q4 2017 Feb 06, 2018	SELL	$189.0 - $222.64 $141,183 - $166,312	-747 Reduced 2.73%	26,658 $5.71 Million
Q3 2017 Nov 01, 2017	BUY	$186.89 - $198.9 $5.12 Million - $5.45 Million	27,405	27,405 $5.37 Million

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sfe Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Sfe Investment Counsel with notifications on news.

Account

Sfe Investment Counsel Becton Dickinson & CO Transaction History